We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Notice for tovorafenib (Ipsen Pty Ltd)
Active ingredients
tovorafenib
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
oral powder for suspension and film coated tablet
Indication
For the treatment of glioma
Therapeutic area
Oncology